| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1049363144 |
| P356 | DOI | 10.2165/00003495-200767120-00003 |
| P698 | PubMed publication ID | 17683169 |
| P50 | author | Karen L. Jones | Q37830816 |
| P2093 | author name string | Michael Horowitz | |
| Christopher K Rayner | |||
| Paul Kuo | |||
| P2860 | cites work | Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes | Q22250887 |
| The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract | Q22252801 | ||
| Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group | Q27860882 | ||
| The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group | Q27861088 | ||
| Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus | Q28144065 | ||
| Effects of an aldose reductase inhibitor, epalrestat, on diabetic neuropathy. Clinical benefit and indication for the drug assessed from the results of a placebo-controlled double-blind study | Q28290548 | ||
| Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial | Q28346269 | ||
| Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia | Q28348673 | ||
| Effects of cisapride on gall bladder emptying, intestinal transit, and serum deoxycholate: a prospective, randomised, double blind, placebo controlled trial | Q28364173 | ||
| The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. | Q30467463 | ||
| Guar gum reduces postprandial hypotension in older people. | Q32028199 | ||
| Relationships of upper gastrointestinal motor and sensory function with glycemic control | Q32050159 | ||
| Gastrointestinal motor mechanisms in hyperglycaemia induced delayed gastric emptying in type I diabetes mellitus | Q33618101 | ||
| Diabetic gastroparesis from autonomic neuropathy: surgical considerations and changes in vagus nerve morphology | Q33619955 | ||
| The patterns of small bowel motility: physiology and implications in organic disease and functional disorders | Q33650334 | ||
| Review article: cardiac adverse effects of gastrointestinal prokinetics | Q33792373 | ||
| Psychologic and psychiatric aspects of gastrointestinal disease | Q34057575 | ||
| Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis | Q81810853 | ||
| Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. DOM-USA-5 Study Group | Q34066979 | ||
| Management of the patient with gastroparesis | Q34128734 | ||
| Electrogastrography: physiological basis and clinical application in diabetic gastropathy | Q34317377 | ||
| Hyperglycaemia stimulates pyloric motility in normal subjects | Q34393861 | ||
| Highly variable gastric emptying in patients with insulin dependent diabetes mellitus | Q34408548 | ||
| Scintigraphic measurement of gastric emptying and ultrasonographic assessment of antral area: relation to appetite | Q34409756 | ||
| Role of cholecystokinin in appetite control and body weight regulation | Q34462432 | ||
| High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study | Q34463851 | ||
| Gastroparesis: prevalence, clinical significance and treatment | Q34482749 | ||
| Gastric emptying in normal subjects--a reproducible technique using a single scintillation camera and computer system | Q34496540 | ||
| A placebo-controlled trial of itopride in functional dyspepsia | Q34496974 | ||
| Functional abdominal pain, psychiatric illness, and life events | Q34528882 | ||
| Gastric emptying in diabetes: clinical significance and treatment. | Q34579697 | ||
| Long-term outcome after gastrectomy for intractable diabetic gastroparesis | Q35041681 | ||
| Oral erythromycin and symptomatic relief of gastroparesis: a systematic review | Q35068003 | ||
| Diabetic gastropathy and prokinetics | Q35068007 | ||
| Clinical significance, pathogenesis, and management of postprandial hyperglycemia | Q35149496 | ||
| Nutrition therapy for diabetic gastroparesis | Q35219428 | ||
| A systematic review of surgical therapy for gastroparesis | Q35565623 | ||
| Role of nitric oxide in the gastric accommodation reflex and in meal induced satiety in humans | Q35594827 | ||
| Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. | Q35598031 | ||
| Treatment of diabetic gastroparesis by high-frequency gastric electrical stimulation | Q35757449 | ||
| Erythromycin in the short- and long-term control of dyspepsia symptoms in patients with gastroparesis | Q35764968 | ||
| Assessment of gastric accommodation: overview and evaluation of current methods. | Q35805966 | ||
| Prandial glucose regulation in the glucose triad: emerging evidence and insights | Q36066526 | ||
| Functional dyspepsia pathogenesis and therapeutic options--implications for management | Q36130570 | ||
| New management approaches for gastroparesis | Q36285947 | ||
| Gastrointestinal motility and glycemic control in diabetes: the chicken and the egg revisited? | Q36384478 | ||
| Treatment of gastroparesis: a multidisciplinary clinical review | Q36428532 | ||
| Gastroparesis: clinical update | Q36476747 | ||
| A comparison between Zhishi Xiaopiwan and cisapride in treatment of functional dyspepsia | Q36491757 | ||
| Clinical practice. Diabetic gastroparesis | Q36741788 | ||
| Efficacy of aprepitant in management of chemotherapy-induced nausea and vomiting | Q36771846 | ||
| Ghrelin gastrokinetic action in patients with neurogenic gastroparesis | Q46903966 | ||
| Acute effects of C-peptide on gastric emptying in longstanding type 1 diabetes | Q46943711 | ||
| Measuring gastric emptying: comparison of 13C-octanoic acid breath test and scintigraphy | Q46989026 | ||
| Effects of fat on gastric emptying of and the glycemic, insulin, and incretin responses to a carbohydrate meal in type 2 diabetes | Q46990563 | ||
| Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis | Q47710455 | ||
| Comparison between coefficient of R-R interval variation and gastric emptying in type 2 diabetes mellitus patients | Q47744603 | ||
| Measuring gastric emptying of semisolids in children using the 13C-acetate breath test: a validation study | Q47988296 | ||
| Glucose responding neurons in the nucleus tractus solitarius of the rat: In vitro study | Q48642982 | ||
| Blood glucose concentration influences postprandial fullness in IDDM. | Q48745573 | ||
| A comparative study of the effects of electroacupuncture and moxibustion in the gastrointestinal motility of the rat. | Q48878458 | ||
| Intragastric distribution and gastric emptying assessed by three-dimensional ultrasonography | Q49110730 | ||
| Effects of cyclooxygenase-2 inhibitor on glucagon-induced delayed gastric emptying and gastric dysrhythmia in dogs. | Q50708055 | ||
| Involvement of nitric oxide in the reflex relaxation of the stomach to accommodate food or fluid | Q50803167 | ||
| There are no morphologic abnormalities of the gastric wall or abdominal vagus in patients with diabetic gastroparesis. | Q50896889 | ||
| Rapid gastric emptying of a solid pancake meal in type II diabetic patients. | Q51019617 | ||
| Psychological distress is linked to gastrointestinal symptoms in diabetes mellitus. | Q51067220 | ||
| An energy algorithm improves symptoms in some patients with gastroparesis and treated with gastric electrical stimulation. | Q51243004 | ||
| Gastric electrical stimulation using endoscopically placed mucosal electrodes reduces food intake in humans. | Q51264289 | ||
| Detection of gastric dysrhythmia using WT and ANN in diabetic gastroparesis patients. | Q51279536 | ||
| Symptom responses, long-term outcomes and adverse events beyond 3 years of high-frequency gastric electrical stimulation for gastroparesis. | Q51300549 | ||
| Post-prandial hyperglycemia is an important predictor of the incidence of diabetic microangiopathy in Japanese type 2 diabetic patients. | Q51511380 | ||
| Absence of the interstitial cells of Cajal in patients with gastroparesis and correlation with clinical findings. | Q51524348 | ||
| Nutrient-induced spatial patterning of human duodenal motor function. | Q51551324 | ||
| Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group. | Q51553882 | ||
| Low-dose intravenous erythromycin: effects on postprandial and fasting motility of the small bowel. | Q51558618 | ||
| Proximal gastric motor activity in response to a liquid meal in type I diabetes mellitus with autonomic neuropathy. | Q51570823 | ||
| Hyperglycemia affects gastric electrical rhythm and nausea during intraduodenal triglyceride infusion. | Q51576547 | ||
| Hyperglycaemia affects proximal gastric motor and sensory function in normal subjects. | Q51582490 | ||
| Comparison between the effects of neostigmine and ranitidine on interdigestive gastroduodenal motility of patients with gastroparesis. | Q51591940 | ||
| Hyperglycemia induces abnormalities of gastric myoelectrical activity in patients with type I diabetes mellitus. | Q51593021 | ||
| Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction. | Q51622063 | ||
| Pyloric dysfunction in diabetics with recurrent nausea and vomiting. | Q51633620 | ||
| Standardization and quantification of radionuclide solid gastric-emptying studies. | Q51676621 | ||
| Further experience with gastric stimulation to treat drug refractory gastroparesis. | Q51785795 | ||
| Upper gastrointestinal symptoms in a U.S. national sample of adults with diabetes. | Q52538398 | ||
| Reliability and interobserver variability of ultrasonographic measurement of gastric emptying rate. | Q52886175 | ||
| Hyperglycemia affects proximal gastric motor and sensory function during small intestinal triglyceride infusion. | Q52906959 | ||
| Effect of atilmotin on gastrointestinal transit in healthy subjects: a randomized, placebo-controlled study. | Q53607459 | ||
| Measurement of gastrointestinal motility in the GI laboratory. | Q53946989 | ||
| Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility. | Q54078327 | ||
| Reduced stem cell factor links smooth myopathy and loss of interstitial cells of cajal in murine diabetic gastroparesis. | Q54614221 | ||
| Euglycaemic hyperinsulinaemia does not affect gastric emptying in Type I and Type II diabetes mellitus | Q57420298 | ||
| Effects of Pancreatic Transplantation on Diabetic Neuropathy | Q60681694 | ||
| 'Gastric' hypoglycaemia - an important concept in diabetes management | Q62479426 | ||
| Effects of fedotozine on gastric emptying and upper gastrointestinal symptoms in diabetic gastroparesis | Q62479703 | ||
| Hyperglycemia attenuates the gastrokinetic effect of erythromycin and affects the perception of postprandial hunger in normal subjects | Q62479739 | ||
| Diabetic autonomic neuropathy | Q66897004 | ||
| Relationship between interdigestive duodenal motility and fluid transport in humans | Q67670715 | ||
| Gastric bezoar formation secondary to gastroparesis diabeticorum | Q67737417 | ||
| Changes in Gastric Emptying in Recipients of Successful Combined Pancreas-Kidney Transplants | Q67878296 | ||
| Disordered gastric emptying: mechanical basis, assessment and treatment | Q37363545 | ||
| Identification and characterization of glucoresponsive neurons in the enteric nervous system. | Q38318054 | ||
| Comparative evaluation of the efficacy and tolerability of itopride hydrochloride and domperidone in patients with non-ulcer dyspepsia. | Q39367917 | ||
| Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial | Q39423996 | ||
| Novel surgical treatment and gastric pathology in diabetic gastroparesis | Q39437997 | ||
| Effect of domperidone on the health-related quality of life of patients with symptoms of diabetic gastroparesis | Q39444353 | ||
| Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study | Q39518005 | ||
| Cardiovascular reflex tests; in the natural history of diabetic autonomic neuropathy. | Q40334798 | ||
| Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy | Q40735749 | ||
| Therapeutic potential of glucagon-like peptide 1 in type 2 diabetes | Q40928196 | ||
| Jejunostomy tube placement in refractory diabetic gastroparesis: a retrospective review | Q41150653 | ||
| Towards a less costly but accurate test of gastric emptying and small bowel transit | Q41152382 | ||
| Increased prevalence of upper gastrointestinal symptoms in long-term type 1 diabetes mellitus | Q43330075 | ||
| Intrapyloric injection of botulinum toxin a for the treatment of persistent gastroparesis following successful pancreas transplantation | Q43618809 | ||
| Predictors of delayed gastric emptying in diabetes | Q43651899 | ||
| The insulinotropic effect of acute exendin-4 administered to humans: comparison of nondiabetic state to type 2 diabetes | Q43913927 | ||
| Validation of a stable isotope gastric emptying test for normal, accelerated or delayed gastric emptying | Q43923612 | ||
| Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The Rancho Bernardo Study | Q44016288 | ||
| Simultaneous measurement of gastric emptying with a simple muffin meal using [13C]octanoate breath test and scintigraphy in normal subjects and patients with dyspeptic symptoms | Q44079347 | ||
| The "electrical way" to cure gastroparesis | Q44110678 | ||
| Standardization of a simplified scintigraphic methodology for the assessment of gastric emptying in a multicenter setting | Q44128889 | ||
| Effect of sildenafil on diabetic gastropathy | Q44155725 | ||
| Measurement of gastric emptying by 13C-octanoic acid breath test versus scintigraphy in diabetics. | Q44234421 | ||
| Inhibitory effects of hyperglycemia on neural activity of the vagus in rats | Q44320920 | ||
| Correlation Between Simultaneous Scintigraphic and Ultrasonographic Measurement of Gastric Emptying in Patients With Type 1 Diabetes Mellitus | Q44444101 | ||
| A modified sonographic technique for assessment of gastric emptying of liquid | Q44444217 | ||
| Effect of altering gastric emptying on postprandial plasma glucose concentrations following a physiologic meal in type-II diabetic patients | Q44447702 | ||
| Guar attenuates fall in postprandial blood pressure and slows gastric emptying of oral glucose in type 2 diabetes | Q44518299 | ||
| Cisapride vs metoclopramide. An acute study in diabetic gastroparesis | Q44546960 | ||
| Effects of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy and gastroparesis. | Q44552857 | ||
| Dual effects of acupuncture on gastric motility in conscious rats | Q44575960 | ||
| Simultaneous 13C/14C dual isotope breath test measurement of gastric emptying of solid and liquid in normal subjects and patients: comparison with scintigraphy | Q44644521 | ||
| Gastroparesis following kidney/pancreas transplant | Q44895114 | ||
| Exendin-4 normalized postcibal glycemic excursions in type 1 diabetes | Q44968815 | ||
| Effect of the motilin agonist KC 11458 on gastric emptying in diabetic gastroparesis | Q44993694 | ||
| The effect of sildenafil on gastric emptying in patients with end-stage renal failure and symptoms of gastroparesis | Q45062185 | ||
| The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus | Q45081231 | ||
| Clinical observation on acupuncture treatment in 35 cases of diabetic gastroparesis. | Q45128592 | ||
| Reduction of Postprandial Hyperglycemia in Subjects With IDDM by Intravenous Infusion of AC137, a Human Amylin Analogue | Q46014136 | ||
| Pramlintide: a human amylin analogue reduced postprandial plasma glucose, insulin, and C-peptide concentrations in patients with type 2 diabetes | Q46182652 | ||
| Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality | Q46366811 | ||
| Insulin-induced hypoglycemia accelerates gastric emptying of solids and liquids in long-standing type 1 diabetes | Q46495818 | ||
| Effects of rikkunshi-to, a traditional Japanese medicine, on the delay of gastric emptying induced by N(G)-nitro-L-arginine | Q46529302 | ||
| The effects of tegaserod, a 5-HT receptor agonist, on gastric emptying in a murine model of diabetes mellitus | Q46721518 | ||
| Effects of pramlintide, an analog of human amylin, on plasma glucose profiles in patients with IDDM: results of a multicenter trial | Q46821083 | ||
| Neural stem cell transplantation in the stomach rescues gastric function in neuronal nitric oxide synthase-deficient mice | Q46847678 | ||
| Relationship of personality characteristics to glucose regulation in adults with diabetes | Q67959776 | ||
| Effect of treatment with cisapride alone or in combination with domperidone on gastric emptying and gastrointestinal symptoms in dyspeptic patients | Q68145891 | ||
| Rapid gastric emptying of an oral glucose solution in type 2 diabetic patients | Q68215612 | ||
| Effects of cisapride on gastroparesis in patients with insulin-dependent diabetes mellitus. A double-blind controlled trial | Q68216995 | ||
| Serum glucose concentration as a modulator of interdigestive gastric motility | Q68257396 | ||
| Vagus nerve morphology in diabetic gastropathy | Q68435590 | ||
| Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies | Q68741659 | ||
| Effect of cisapride on gastric and esophageal emptying in insulin-dependent diabetes mellitus | Q68989565 | ||
| Impaired gastric emptying in diabetic patients with cardiac autonomic neuropathy | Q69210564 | ||
| Hyperglycaemia and absorption of sulphonylurea drugs | Q69371278 | ||
| Gastric emptying in patients with insulin-requiring diabetes mellitus | Q69710503 | ||
| Diabetic gastroparesis: an abnormality of gastric emptying of solids | Q69894985 | ||
| Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus | Q70245065 | ||
| Gastroparesis: an important cause of hospitalization in continuous ambulatory peritoneal dialysis patients and the role of erythromycin | Q70481461 | ||
| Reduced postprandial blood glucose levels in recently diagnosed non-insulin-dependent diabetics secondary to pharmacologically induced delayed gastric emptying | Q70530835 | ||
| Effects of erythromycin on gastric emptying, alcohol absorption and small intestinal transit in normal subjects | Q70616075 | ||
| Gastric emptying in patients with diabetes mellitus | Q71259331 | ||
| Gastrokinetic effects of levosulpiride in dyspeptic patients with diabetic gastroparesis | Q71551384 | ||
| [13C]octanoic acid breath test for non-invasive assessment of gastric emptying in diabetic patients: validation and relationship to gastric symptoms and cardiovascular autonomic function | Q71557602 | ||
| Hyperglycemia affects cardiovascular autonomic nerve function in normal subjects | Q71617302 | ||
| Gastric emptying in early noninsulin-dependent diabetes mellitus | Q71664807 | ||
| Treatment with an oral proteinase inhibitor slows gastric emptying and acutely reduces glucose and insulin levels after a liquid meal in type II diabetic patients | Q72048522 | ||
| Mediation of hyperglycemia-evoked gastric slow-wave dysrhythmias by endogenous prostaglandins | Q72590080 | ||
| Chronic administration of levosulpiride and glycemic control in IDDM patients with gastroparesis | Q73063301 | ||
| Simultaneous measurement of gastric emptying of a solid meal by ultrasound and by scintigraphy | Q73081911 | ||
| Slow gastric emptying in type I diabetes: relation to autonomic and peripheral neuropathy, blood glucose, and glycemic control | Q73112482 | ||
| Evidence of accelerated gastric emptying in longstanding diabetic patients after ingestion of a semisolid meal | Q73384814 | ||
| Effect of antioxidants on pyrogallol-induced delay in gastric emptying in rats | Q73407399 | ||
| Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus | Q73475858 | ||
| Ultrasonography and gastric emptying in children: validation of a sonographic method and determination of physiological and pathological patterns | Q73538903 | ||
| Idiopathic and Diabetic Gastroparesis | Q73626784 | ||
| Gastric electrical stimulation for medically refractory gastroparesis | Q73735575 | ||
| Proximal gastric compliance and perception of distension in type 1 diabetes mellitus: effects of hyperglycemia | Q73793527 | ||
| Long-term effects of pancreatic transplantation on diabetic neuropathy | Q73929303 | ||
| Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis | Q74148589 | ||
| Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle | Q74503010 | ||
| Natural history of diabetic gastroparesis | Q74655532 | ||
| Which form of erythromycin should be used to treat gastroparesis? A pharmacokinetic analysis | Q74836731 | ||
| The influence of cisapride on gastric tone and the perception of gastric distension | Q77192633 | ||
| The effect of erythromycin on gastric emptying is modified by physiological changes in the blood glucose concentration | Q78120448 | ||
| Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe | Q78191116 | ||
| Hospitalizations and outcomes for diabetic gastroparesis in North Carolina | Q78829391 | ||
| A deficiency of gastric interstitial cells of Cajal accompanied by decreased expression of neuronal nitric oxide synthase and substance P in patients with type 2 diabetes mellitus | Q79424153 | ||
| Influence of intrapyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patients | Q80109502 | ||
| Gastric emptying in patients with Type 2 diabetes mellitus and diabetes associated with mitochondrial DNA 3243 mutation using 13C-octanoic acid breath test | Q80205097 | ||
| Pathophysiology of functional dyspepsia | Q80482720 | ||
| Diabetic neuropathy | Q80746741 | ||
| Gastric electrical stimulation results in improved metabolic control in diabetic patients suffering from gastroparesis | Q81301768 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 1671-1687 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | Drugs | Q3040094 |
| P1476 | title | Pathophysiology and management of diabetic gastropathy: a guide for endocrinologists | |
| P478 | volume | 67 |
| Q48465254 | A loss of social eating: the experience of individuals living with gastroparesis |
| Q33564976 | Atrial natriuretic peptide signal pathway upregulated in stomach of streptozotocin-induced diabetic mice |
| Q33887129 | Combination of symptoms, syndrome and disease: treatment of refractory diabetic gastroparesis |
| Q41815798 | Effect of Glucose Control on Delayed Gastric Emptying in Diabetic Patients: Author's Reply |
| Q42618358 | Effect of glucose control on delayed gastric emptying in diabetic patients. |
| Q42911684 | Effects of metoclopramide on duodenal motility and flow events, glucose absorption, and incretin hormone release in response to intraduodenal glucose infusion |
| Q37842446 | Enteral nutrition in patients with severe traumatic brain injury: reasons for intolerance and medical management |
| Q37436502 | Pathophysiology and management of gastroparesis. |
| Q33788332 | Randomised clinical trial: ghrelin agonist TZP-101 relieves gastroparesis associated with severe nausea and vomiting--randomised clinical study subset data. |
Search more.